SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-045252
Filing Date
2021-02-16
Accepted
2021-02-16 17:22:55
Documents
5
Period of Report
2021-02-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d129003d8k.htm 8-K 20891
2 EX-10.1 d129003dex101.htm EX-10.1 11824
3 EX-99.1 d129003dex991.htm EX-99.1 8408
4 GRAPHIC g129003dsp11headerlogo.jpg GRAPHIC 10817
5 GRAPHIC g129003dsp5.jpg GRAPHIC 4382
  Complete submission text file 0001193125-21-045252.txt   63639
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Filer) CIK: 0001661181 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37906 | Film No.: 21640974
SIC: 2834 Pharmaceutical Preparations